Document is current
Any future updates will be listed below
-
Authors
Sweere, Vera
Slot, Alexandra Bruins
Hermsen, Rick
Heetman, Joris G.
Wever, Lieke
Lavalaye, Jules
Vinken, Maarten
Bahler, Clinton D.
Tann, Mark
Kesch, Claudia
Telli, Tugce
Fendler, Wolfgang P.
Chiu, Peter Ka-Fung
Zattoni, Fabio
Evangelista, Laura
Ceci, Francesco
Miszczyk, Marcin
Rajwa, Pawel
Barletta, Francesco
Briganti, Alberto
Montorsi, Francesco
Gandaglia, Giorgio
van Basten, Jean-Paul A.
van Melick, Harm H.E.
van den Bergh, Roderick C.N.
Marra, Giancarlo
Scheltema, Matthijs J.V.
Soeterik, Timo F.W. https://orcid.org/0000-0002-0259-8750
,
- License Information
-
More Information
Article History
Received: 17 April 2025
Accepted: 4 July 2025
First Online: 28 July 2025
Declarations
:
: The Medical research Ethics Committees United (MEC-U) has reviewed the study protocol, and waived the need for (MEC-U) approval (AW24.048/W18.055). Institutional Review Boards approved of the study prior to initiating data collection.
: The requirement to obtain informed consent was waived due to the retrospective nature of the study.
: RH received consultancy fees from ABX advance biochemical compounds GmbH and Blue Earth Diagnostics. WF reports fees from SOFIE Bioscience (research funding), Janssen (consultant, speaker), Perceptive (consultant, image review), Bayer (consultant, speaker, research funding), Novartis (speaker, consultant), Telix (speaker), GE Healthcare (speaker, consultant), Eczacıbaşı Monrol (speaker), Abx (speaker), Amgen (speaker), Urotrials (speaker), Lilly (consultant), AstraZeneca (research funding) outside of the submitted work.
